7/25/2019 Syok DepKes AP

1/20

7/25/2019 Syok DepKes AP

2/20

!"#$ &'(&')*$+,-# .'+')/$)$) /'+-$0$& "12.

!"#$ %&'()'*"# ,$*-)*. /$"$0 1'*#*.($-$* 234

3'4$"$ 56 768

7 9$-,) 766 786

:$1# :$+, ;$-#+ 7

7/25/2019 Syok DepKes AP

3/20

9'.$)$)3$+$-

>,+$-

?$)/,)*

@'"#"/')"#A$".,B$+

C#"/'(#.

D"# C'.,)E,&

3')1,/ ?$)/,)*!"#$%&'()

F2)/+$./#B#/$"

*%$&'()

7/25/2019 Syok DepKes AP

4/20

D)0'." "12.

G+'.,')"# ?$)/,)*

H$./, &')*#"#$) .$B'+

9'.$)$) 3$+$-

3$(&$. .'-#B$)*$) E$#+$) #)/+$I$".,B$+

J=6 (;K.* J

7/25/2019 Syok DepKes AP

5/20

9$.#.$+0#

M$0# B'($-

N#&2/')"#

O'+P,"# Q$+#)*$) R,+,.

H$./, &')*#"#$) .$B'+ S = 0'/#.

F'"$0$+$) ('),+,)O+20,."# ,+#)' ('),+,)

TUV:U@UM F;DMDC CWXF OY3DU9@DF

A. Pudjia!

7/25/2019 Syok DepKes AP

6/20

JAMA. 1991;266:1242-1245

Based on our findings, repeated 20-mL/kg fluidboluses may be administered in excess of 60 mL/kg

in the first hour, and 120 mL/kg in the first 6 hours ifblood pressure, peripheral pulses, mental status,

arterial blood gas levels, urine output, and peripheral

color suggest that perfusion remains decreased.

7/25/2019 Syok DepKes AP

7/20

JO+JM$JO+JM$JO+JM$

M$J>B

U :

7/25/2019 Syok DepKes AP

8/20

LahirDewasa

Cairan Tubuh Total

Cairan Intrasel

Cairan EkstraselBeratb

adan(%)

Friis Hansen 1961

7/25/2019 Syok DepKes AP

9/20

M$>B 6Z[\7L6 (;

8\ UBR,(#)7L6 (;

]Z= ;7Z= ; 6Z< ;

]Z= ;7Z]= ; 6Z$#+$)D)/+$"'B

>$#+$)D)/'+"/#/#$B

YP'. M$>B 6Z[\ 0$) UBR,(#) 8\ &$0$ $)$. ,"#$ 7 /$-,) 0')*$) R'+$/ ^ .*

7/25/2019 Syok DepKes AP

10/20

Deroy, Current Anaesthesia and Critical Care (2000) 11, 2026

Characteristic of Colloids

7/25/2019 Syok DepKes AP

11/20

G+'.,')"# Q$)/,)* )2+($BZ "'",$# ,"#$

F,$B#/$" )$0# R$#.Z /#0$. $0$ &'+R'0$$) &'+#P'+ 0$) "')/+$B

U.+$B -$)*$/

H$./, &')*#"#$) .$B'+ _ = 0'/#.

F'"$0$+$) R$#.

O+20,."# ,+#)' S 7 (BK.*KQ$(

9'.$)$) 0$+$- )2+($BZ "'",$# ,"#$

5$&.'- 67$0A. Pudjia!

7/25/2019 Syok DepKes AP

12/20

:UTUDVUMU VYMD;UD 9Y@;U;! :UMWUF >UD@UM`

O'(R'"$+$) -$/#

@2).-# R$"$- -$B," /#0$. )1$+#)*

!9'.$)$) I')$ Q,*,B$+#"

G2/2 /2+$."

!B/$"2)2*+$a A')$ >$I$ D)P'+#2+

7/25/2019 Syok DepKes AP

13/20

G2/2 92+$." T$*$B ?$)/,)* F2)*'"/#P

8'&$9$- :;+'0#"/+#R,"# I$".,B$+ &$+,

8'&$9$-

7/25/2019 Syok DepKes AP

14/20

!"#$%#&'( *#&+,'"- ./01 234(34,'"

*#56$+,'"-

7,%'"#"-

8'9%'"#"-

:&'"-&;%'"- < 1=> 234(34,'"

?+@#&%-@@#% *#&+,'"- A01 234(34,'"B#%-&'"-&;%'"-

C;-"D9-&;%'"-

:&'"-&;%'"- A 1=> 234(34,'"

?+@#E'9+$#% B'$%#&%6@'E-

B'$%#39DF-%'"-C;-"$#9+,'"-

A. Pudjia!

7/25/2019 Syok DepKes AP

15/20

3X=b7c]LdNRdC$/e6c66]dO$X= TB,.2"$

C#.B," F+'R

.'.,+$)*$) U9O b C12.C12. -#&2."#.C12. #".'(#.C12. $)'(#.

C12. TB#.2&')#.

A. Pudjia!

7/25/2019 Syok DepKes AP

16/20

=LC'&"#"

^D)",a"#')"# +'B$/#P 7^M2+($B

+%,(- */)01()12 3454

D)",a"#')"# U0+')$B &$0$ C'&"#" O'0#$/+#.

8C12. "'&/#. 76C12. "'&/#.

=C12. +'"#"/') .$/'.2B$(#) ]C12. +'"#"/') .$/'.2B$(#)

A. Pudjia!

7/25/2019 Syok DepKes AP

17/20

DO2= Cardiac Outputx Arterial Oxygen Content

Frekuensi Jantung X Stroke Volume Hb X 1,34 X SaO2

PreloadKontraktilitas Afterload

Tranfusi

PerbaikipH, pCO2,temperatur

Perbaiki pernapasan/terapi oksigen

Cairan Inotropik Vasodilator/Vasopressor

7/25/2019 Syok DepKes AP

18/20

5$&.'- 5'&$># 0$*9)-

F$0$+ B$./$/ ('),+,) f$/$, $)#2) *$& ('),+,)g

C$/,+$"# I')$ E$I$ S56\6(%)1(7 18)$9S]c] $)0 _Lc6 ;K(#)K(=0')*$)/'.$)$) &'+P,"# )2+($B "'",$# ,"#$

F$0$+ *,B$ 0$+$- )2+($B 0')*$):&/7';$ 18"/;1'8%(#$;1$)* )2+($B

C'&"#" &'0#$/+#.

7/25/2019 Syok DepKes AP

19/20

V'(R,.$ Q$B

V')*')$B 9$)0$ C12.

) )$&$" 0$) V'($"$)* $."'" I$".,B$+

:'+#.$) E$#+$) + ","#/$"# "$(R#B (')*'I$BF2+'."# -#&2*B#.'(#$

$"# +'"&2) .B#)#"

C12. /'+$/$"#O'($)/$,$) h $/$"#

&')1'R$R "12.

C12. /#0$. /'+$/$"# 0'9#/+$"# 02&$(#)'

;$.,.$) &

)*$) E$#+$) +'","#/$"# $/$, ')'&-+#)'

($)/$,$)

C12. /#0$. /'+$/$"#U0$

')*$) E$#+$) 0$) 02&$(.$- +#"#.2 #)",a"#')"# $0+'

#) $/$, ')'&-+#)' )$B`

U0$ +#"#.2:'+#.$) -#0+2.2+/#"2)

9#0$. $?$)*$) R'+#.$

$ +#"#.2 -#0+2.2+/#"2)

C12. R'B,( /'+$/$"#

6'&) ;(%, ;

7/25/2019 Syok DepKes AP

20/20

C12. -$+," 0#E,+#*$# &$0$ $)$. 0')*$) *$)**,$) &'+P,"#Z /$.#.$+0#$Z.,$B#/$" )$0# B'($- 0$) $/$, -#&2/')"#

C#P$/ .2B2#0 0#&')*$+,-# /'.$)$) 2).2/#. 0$) ('/$R2B#"('

F'B'R#-$) E$#+$) -$+," 0#E,+#*$# R#B$ 0#/'(,.$) &'(R'"$+$) -$/#$.,/Z &')#)*.$/$) ?AOZ /#(R,B)1$ +2).# R$"$-Z $/$, /'+0')*$+)1$#+$($ 0'+$&

T$*$B Q$)/,)* .2)*'"/#P ('(R'+#.$) *$(R$+$) P2/2 /2+$." R'+,&$i+'0#"/+#R,"# I$".,B$+ &$+,Z '0'($ #)/'+"/#/#$B 0$) '0'($ $BI'2B'+"'",$# 0'+$Q$/)1$

D)2/+2. h I$"2$./#P 0#R'+#.$) "'/'B$- +'","#/$"# E$#+$) 1$)* $0'.,$/

D)",a"#')"# $0+')$B 0$&$/ (')*$.#R$/.$) "12. +'"#"/') .$/'.2B$(#)

O#B#-$) E$/-'E2B$(#)' 7'&) ;